The proliferation of substandard medicines represents a deeply concerning problem facing the global medical landscape. These bogus products, often mimicking legitimate medications, pose a significant danger to individual safety, undermining therapy effectiveness and potentially leading to severe negative health outcomes. Motivated by substantial fi